Skip to main navigation Skip to search Skip to main content

Amphotericin B formulations exert additive antifungal activity in combination with pulmonary alveolar macrophages and polymorphonuclear leukocytes against Aspergillus fumigatus

  • Emmanuel Roilides
  • , Caron A. Lyman
  • , Joanna Filioti
  • , Onome Akpogheneta
  • , Tin Sein
  • , Cristina Gil Lamaignere
  • , Ruta Petraitiene
  • , Thomas J. Walsh

Research output: Contribution to journalArticlepeer-review

Abstract

Deoxycholate amphotericin B (DAMB) and amphotericin B lipid complex (ABLC) additively augmented the fungicidal activity of pulmonary alveolar macrophages against the conidia of Aspergillus fumigatus. DAMB, ABLC, and liposomal amphotericin B similarly displayed additive effects with polymorphonuclear leukocytes in damaging the hyphal elements of A. fumigatus.

Original languageEnglish (US)
Pages (from-to)1974-1976
Number of pages3
JournalAntimicrobial agents and chemotherapy
Volume46
Issue number6
DOIs
StatePublished - 2002
Externally publishedYes

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'Amphotericin B formulations exert additive antifungal activity in combination with pulmonary alveolar macrophages and polymorphonuclear leukocytes against Aspergillus fumigatus'. Together they form a unique fingerprint.

Cite this